Baillie Gifford & Co’s AbCellera Biologics ABCL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.5M | Sell |
10,360,004
-835,828
| -7% | -$2.87M | 0.03% | 165 |
|
|
2025
Q1 | $25M | Sell |
11,195,832
-1,040,633
| -9% | -$2.32M | 0.02% | 171 |
|
|
2024
Q4 | $35.9M | Sell |
12,236,465
-658,238
| -5% | -$1.93M | 0.03% | 158 |
|
|
2024
Q3 | $33.5M | Sell |
12,894,703
-9,016,311
| -41% | -$23.4M | 0.03% | 161 |
|
|
2024
Q2 | $64.9M | Sell |
21,911,014
-1,269,075
| -5% | -$3.76M | 0.05% | 129 |
|
|
2024
Q1 | $105M | Sell |
23,180,089
-864,707
| -4% | -$3.92M | 0.08% | 122 |
|
|
2023
Q4 | $137M | Sell |
24,044,796
-2,159,853
| -8% | -$12.3M | 0.11% | 118 |
|
|
2023
Q3 | $121M | Sell |
26,204,649
-160,102
| -0.6% | -$736K | 0.11% | 114 |
|
|
2023
Q2 | $170M | Buy |
26,364,751
+6,535,100
| +33% | +$42.2M | 0.14% | 104 |
|
|
2023
Q1 | $150M | Buy |
19,829,651
+132,916
| +0.7% | +$1M | 0.13% | 105 |
|
|
2022
Q4 | $200M | Buy |
19,696,735
+6,339,067
| +47% | +$64.2M | 0.21% | 89 |
|
|
2022
Q3 | $132M | Buy |
13,357,668
+2,953
| +0% | +$29.2K | 0.14% | 104 |
|
|
2022
Q2 | $142M | Buy |
13,354,715
+2,305,950
| +21% | +$24.6M | 0.15% | 106 |
|
|
2022
Q1 | $108M | Buy |
11,048,765
+7,474,857
| +209% | +$72.9M | 0.08% | 136 |
|
|
2021
Q4 | $51.1M | Buy |
3,573,908
+333,365
| +10% | +$4.77M | 0.03% | 185 |
|
|
2021
Q3 | $64.9M | Buy |
3,240,543
+515,346
| +19% | +$10.3M | 0.03% | 167 |
|
|
2021
Q2 | $60M | Buy |
2,725,197
+1,569,844
| +136% | +$34.5M | 0.03% | 177 |
|
|
2021
Q1 | $39.2M | Buy |
+1,155,353
| New | +$39.2M | 0.02% | 196 |
|